WallStreetZenWallStreetZen

NASDAQ: VRDN
Viridian Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Viridian Therapeutics earnings were -$344.1M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest VRDN earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$100.7M, up 15.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VRDN reported annual earnings of -$269.9M, with 13.6% growth.

VRDN earnings history

Current Revenue
$305.0k
Current Earnings
-$344.1M
Current Profit Margin
-112,806.9%

VRDN Return on Equity

Current Company
-55.1%
Current Industry
-9%
Current Market
27%
VRDN's Return on Equity (-55.1%)... subscribe to Premium to read more.
High Return on Equity Performance

VRDN undefined

Current Company
-49.9%
Current Industry
0.3%
VRDN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when VRDN announces earnings.

VRDN undefined

Current Company
-64.39%
Current Industry
8.2%
VRDN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VRDN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
VRDN-$340.63M-$344.06MN/A-$3.11
EWTX-$148.35M-$150.70MN/A-$1.55
JANX-$75.70M-$77.74MN/A-$1.35
WVE-$121.20M-$129.87MN/A-$0.80
NVAX$495.57M$422.82MN/A$2.60
View Top Biotech Stocks

Viridian Therapeutics Earnings Reports & History FAQ

What were Viridian Therapeutics's earnings last quarter?

On VRDN's earnings call on Invalid Date, Viridian Therapeutics (NASDAQ: VRDN) reported Q2 2025 earnings per share (EPS) of -$1.00, up 29.87% year over year. Total VRDN earnings for the quarter were -$100.74 million. In the same quarter last year, Viridian Therapeutics's earnings per share (EPS) was -$0.77.

If you're new to stock investing, here's how to buy Viridian Therapeutics stock.

Is Viridian Therapeutics profitable or losing money?

As of the last Viridian Therapeutics earnings report, Viridian Therapeutics is currently losing money. Viridian Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$344.06 million, a 50.87% increase year over year.

What was VRDN's earnings growth in the past year?

As of Viridian Therapeutics's earnings date in Invalid Date, Viridian Therapeutics's earnings has grown year over year. VRDN earnings in the past year totalled -$344.06 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.